Puthillath, Ajithkumar <br/><br/>
A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer.  [electronic resource] 

 -  Critical reviews in oncology/hematology  Sep 2009 
 - 242-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0461 
<br/><br/><label>Standard No.: </label>10.1016/j.critrevonc.2008.10.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bevacizumab<br/>Capecitabine<br/>Carcinoma--drug therapy<br/>Colorectal Neoplasms--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Neoadjuvant Therapy<br/>Neoplasm Metastasis<br/>Survival Analysis<br/>Treatment Outcome